Diagnosis, Imaging, and Tests

Diagnosing vascular dementia is like solving a three-part puzzle. It is not enough for a doctor to simply see a “bad scan” or note that you have high blood pressure. To confirm a diagnosis, your medical team looks for a cognitive syndrome (evidence of thinking changes), cerebrovascular disease (visible damage on a brain scan), and a clear, logical link between the two ^[1][2]. A proper assessment also includes a detailed functional history, a neurological examination, a medication review, and tests for potentially reversible contributors such as delirium, thyroid abnormalities, vitamin B12 deficiency, sleep apnea, or depression.

This process helps your doctor determine whether your symptoms are caused purely by blood vessel issues or if they are part of a mixed dementia involving other conditions like Alzheimer’s ^[1][3].

The Imaging “Map”: MRI vs. CT

Imaging is the most powerful tool for seeing how vascular disease has affected your brain. While a CT scan can be a helpful backup, the Magnetic Resonance Imaging (MRI) is considered the preferred imaging test because it can see much smaller and more subtle changes ^[4][5].

Doctors look for several specific markers on your MRI:

• White-Matter Hyperintensities (WMH): These appear as bright white “clouds” or spots on certain MRI sequences (specifically the FLAIR sequence) ^[4]. They represent damage to the brain’s “wiring” caused by a chronic lack of blood flow ^[6]. They can indicate damage from vascular disease, but they are also common with typical aging, migraines, or inflammation, so their presence alone does not prove dementia.
• Lacunar Infarcts: These are very small, deep strokes that leave behind tiny, fluid-filled cavities (lacunes) ^[4]. They are often “silent,” meaning you may not have realized they happened at the time ^[7].
• Microbleeds: These are tiny, old leaks from fragile blood vessels deep in the brain. They can have different patterns and causes, including deep hypertensive arteriopathy or lobar cerebral amyloid angiopathy. Specialists use a specific sequence called susceptibility-weighted imaging to find these “ink spots” ^[4].
• Strategic Infarcts: Sometimes, a single stroke in a “strategic” location—like the thalamus or caudate nucleus—can cause significant cognitive changes even if the stroke itself was small ^[8][9].

Importantly, there is no universal “threshold” or specific number of spots required for a diagnosis ^[10]. One person might have many spots and few symptoms, while another might have only a few spots in critical areas that cause significant trouble ^[11][8].

Measuring Thinking: MoCA vs. MMSE

To measure the “cognitive syndrome” part of the puzzle, doctors use screening tests. Two of the most common are the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).

For vascular dementia, the MoCA is often preferred ^[12]. This is because vascular disease typically hits executive function—your ability to plan, organize, and focus—earlier than it hits short-term memory ^[6]. The MoCA includes tasks like “trail-making” (connecting dots) and clock-drawing that are much more sensitive to these specific vascular deficits ^[12][13]. The MMSE is still widely used and can be helpful in post-stroke settings, but it can sometimes miss the milder planning and attention issues common in vascular cognitive impairment ^[14][13]. Both are screening tools affected by factors like education, fatigue, hearing, and vision; they are not definitive diagnostic tests, and a functional history or formal neuropsychological testing is often needed to understand your true cognitive profile.

Distinguishing Pure vs. Mixed Dementia

Since mixed pathology is common ^[15], doctors may use biomarkers to see what else is happening in the brain ^[3].

• Cerebrospinal Fluid (CSF) Testing: A lumbar puncture (spinal tap) allows doctors to collect cerebrospinal fluid, the liquid that bathes the brain. By measuring the ratios of specific proteins like amyloid and tau, they can determine if Alzheimer’s disease is co-existing with the vascular damage ^[16][17].
• Amyloid PET Scans: This is a specialized brain scan where a tracer is injected into your vein to “light up” amyloid plaques, the hallmark of Alzheimer’s ^[18]. A positive scan doesn’t mean the vascular damage isn’t important; it shows amyloid pathology is present, but it does not by itself prove that Alzheimer’s disease is the primary cause of your symptoms, as amyloid becomes more common with age. These tests have costs and procedural considerations, and they are usually reserved for diagnostically uncertain cases where confirming Alzheimer’s pathology would alter your treatment plan ^[3].

By combining these tests, your care team can move beyond a simple “vascular” or “Alzheimer’s” label and create a personalized plan that addresses every factor contributing to your cognitive health ^[1][19].